IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
about
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumUnraveling insulin-like growth factor binding protein-3 actions in human diseaseCadmium exposure and risk of prostate cancer: a meta-analysis of cohort and case-control studies among the general and occupational populationsmRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancerSmall is beautiful: insulin-like growth factors and their role in growth, development, and cancerAn analysis of growth, differentiation and apoptosis genes with risk of renal cancer.Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.A polymorphism at IGF1 locus is associated with anemia.Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels.Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansInsulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.Circulating IGF1 and IGF2 and SNP genotypes in men and pregnant and non-pregnant women.A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme.Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study.Genetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women.Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsEighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancerGenetic variability in IGF-1 and IGFBP-3 and body size in early lifeIdentification of genetic determinants of IGF-1 levels and longevity among mouse inbred strains.Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal CancerAssociations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degenerationCommon genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer riskCirculating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumorsInsulin-like growth factor 1 gene polymorphism and breast cancer risk among arab omani women: a case-control studyEffects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical IllnessInsulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancerPolymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.IGF gene polymorphisms and breast cancer in African-American and Hispanic women.Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
P2860
Q24614574-F6503850-9CD5-44A4-B77F-E9EF3328D044Q24650060-5EFA14BD-E750-416C-81C5-B77F789AE3A9Q28394157-40BAA4A5-E1A0-4A7E-8989-3F9727D4C238Q28543647-292F4C9F-67AE-4CEE-A2FD-54229B39BA1CQ30395770-CB3E077A-27EA-4121-BC9B-0557C3E6B269Q33482168-EA307144-3404-4EF8-9C37-75AD69FE6A03Q33543396-2BD85915-4642-4505-8F30-700AB9DD2594Q33569159-CB171F31-30E1-4098-8128-DEB2AF927D52Q33779097-EAC4534F-CA4A-4559-A1D3-8197EFEF1B0AQ33848720-E694DB87-5227-44C6-9A30-12FD8CB7DFBEQ33916825-D1627093-4934-4737-9D17-515DFEFBB588Q33958230-7AB40D4F-9E92-48E8-A59B-6345AB938287Q33980349-A793CD39-B863-4D00-B9DC-799798725A63Q34023117-51E76A6A-057E-4909-AF27-1AE688D98349Q34078803-881ED852-9848-4381-86A8-A7AE32268C0FQ34118391-7BEBCC3D-B61A-4660-9198-053FE504C6CEQ34130759-5F7F44F9-A3B6-414C-88F4-1FC1F16DED95Q34291613-AD3D1900-4CFA-4DF2-B2D7-BDF63DC20C90Q34294117-B6941A89-34C9-4D20-98A2-2B84981F13DBQ34316522-4BF25A3A-B734-4848-A3D6-23D07FB76E76Q34338886-2F5F37C7-22E5-49D9-9761-10324773901CQ34380477-2A2D4F73-E438-4EED-B838-DFD30A0EA8F2Q34512347-6B171C6B-F7A8-4E93-9E78-D6862E4DAC13Q34636364-65BB1344-825B-40E5-8506-5BE725DD2552Q35193839-C6B82B7D-8C93-470D-8B90-3C7C0233B466Q35340995-4A95B8C4-28EF-4732-8DE7-0E49466C88ADQ35596135-22292252-6BCE-43DF-8DF2-445590BF35A1Q35615218-E78C2974-85A9-4A16-9A18-590F0A38BBA8Q35805508-3B218F2F-E8A5-4EE1-9565-8B1763E17FF6Q35826255-FB93EEE3-39E2-4D9F-B039-98BCEA40437EQ35858395-0ED3251E-9F16-409D-A612-43BFCE38139CQ35925906-70BC4BCF-6374-4CA2-89F9-FD574E6E06E5Q36111455-A51B965F-3E6C-4982-BCDB-C5BB02DFAED6Q36134212-4D426381-1C3F-4362-B1EA-D1D9BA7DD5D5Q36296818-ED4ADB62-5FCD-4839-B007-392EB488212CQ36433403-A4B157B9-97CC-47B7-A34D-7BF9723AF10CQ36581469-2B313B71-3DC7-40FF-98D2-C9A70C6B2731Q36978703-F3D93D66-2711-47F0-BEC6-FD09E4AFBED3Q37095826-37C535EC-A9BB-445E-9128-9CB00A69592FQ37441195-9E31248F-7A00-46BB-AA4A-56AD942EF907
P2860
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@ast
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@en
type
label
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@ast
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@en
prefLabel
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@ast
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@en
P2093
P2860
P50
P1433
P1476
IGF-1, IGFBP-1, and IGFBP-3 po ...... ncer Cohort Consortium (BPC3).
@en
P2093
Alpa V Patel
Breast and Prostate Cancer Cohort Consortium
Christine D Berg
Daniel O Stram
Eugenia E Calle
Iona Cheng
Jonas Manjer
Laure Dossus
Laurence N Kolonel
Malcolm C Pike
P2860
P356
10.1371/JOURNAL.PONE.0002578
P407
P50
P577
2008-07-02T00:00:00Z